| 90.78 Data as of Jun 06 |  +3.09 / +3.52%Today’s Change | 43.58 Today|||52-Week Range 101.57 | +20.19% Year-to-Date |
| Aveo's Future Depends on Triple-Negative Breast Cancer Jun 06 / TheStreet.com | Onyx Stock Falls On Unusually High Volume (ONXX) Jun 03 / TheStreet.com |
| Positive Data on Bayer/Onyx's Nexavar - Analyst Blog Jun 03 / Zacks.com | Mid-week Update – 05/08/2013 May 08 / StockTwits |
| Previous close | 87.69 |
| Today’s open | 87.75 |
| Day’s range | -- - -- |
| Volume | 1,136,423 |
| Average volume (3 months) | 1,223,065 |
| Market cap | $6.4B |
| Dividend yield | -- |
| Earnings growth (last year) | -342.02% |
| Earnings growth (this year) | +31.89% |
| Earnings growth (next 5 years) | +29.00% |
| Revenue growth (last year) | -19.01% |
| P/E ratio | NM |
| Price/Sales | 13.59 |
| Price/Book | 7.22 |
| Today’s change | Today’s % change | |
|---|---|---|
| RDYDr.Reddy's Laborator... | +0.63 | +1.69% |
| ELNElan Corporation PLC | +0.03 | +0.24% |
| PCYCPharmacyclics Inc | +3.69 | +4.42% |
| HSPHospira Inc | +0.54 | +1.57% |
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $362.2M |
| Annual profit (last year) | -$187.8M |
| Net profit margin | -51.85% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer N. Anthony Coles, Jr., MD |
Chief Financial Officer & Executive Vice President Matthew K. Fust, MBA |
Corporate headquarters South San Francisco, California |
.
